Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
COLL
— Collegium Pharmaceutical, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
NOV 6, 2025
REVENUE
$209.4M
+11.4%
NET MARGIN
15.0%
+8.7 PTS
EPS
$1.00
+163.2%
FREE CASH FLOW
$78.3M
+8.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 4 OF 4
OLDER CALL →